Press Releases

The report comprises “Global Organ-On-Chip Market Research Report: By Model Type (Organ-Based Model, Disease-Based Model), By Material (Polydimethylsiloxane (PDMS), Polymer, Glass), By Solution (Products [Instruments, Consumables & Accessories, Software], Services [Custom Services, Standard Services]), By Organ Type (Liver, Intestine, Kidney, Lung, Heart, Other organs), By Application (Toxicology Research, Drug Discovery, Physiological Model Development, Stem cell Research, Tissue regeneration, and regenerative Medicines, Others), By End User (Pharmaceutical and Biotechnology Companies, Cosmetics Industry, Academic and Research Institutes, Others) and Others Forecast (2025-2030)”, according to the report, the Global Organ-on-Chip Market size was valued at around USD 126 million in 2024 and is projected to reach USD 950 million by 2030. Along with this, the market is estimated to grow at a CAGR of around 40% during the forecast period (2025-30). 

What’s New in the Growing Industry

The growing development of multi-organ-on-chip systems offers lucrative opportunities for the expansion of the organ-on-chip market. These complex models can better mimic complicated interactions between different organs by allowing more realistic simulations of human physiology. Additionally, the ongoing demand for rapid medical countermeasures facilitates exponential growth of the organ-on-chip industry. This resulted in growing collaboration between research institutions and government agencies to develop rapid medical countermeasures against health security threats. Therefore, resulted in bolstering the expansion of the Organ-On-Chip industry.

Conclusion

The blog comprises Global market players in the Organ-on-chip industry, with market product information. This blog entails details regarding the prominent factors behind the surging demand for futuristic growth and new opportunities that facilitate market development. Market players such as Altis Biosystems, AlveoliX AG, Axosim, Bi/ond Solutions B.V, Cherry Biotech, CN-Bio, Emulate, Inc., Hesperos, Inc., Insphero, MesoBioTech, Mimetas B.V., Nortis Inc., React4Life, TARA Biosystems (Valo Health), TissUse GmbH and Others leading companies, facilitate revolutionizing the global market and promoting a secure future for the Organ-on-chip market.